ONE-TWENTY TWO: Trading Financial Markets
Exploring the poetry in financial markets for students of money and economy since the year 2000.
I have been a fan of genetic testing company Invitae (NVTA) for six years. My interest started after I heard co-founder (and now President, CEO, and Chairman) Sean George give a talk at the Stanford Technology Ventures Program. He titled the 2015 talk “Experience Is Your Reward.” George talked about facing down challenges and adversity … Read more
Soliton (SOLY) is a pre-launch medical device company specializing in technology for tattoo removal and cellulite reduction. The company is working on extending its RAP (Rapid Acoustic Pulse) technology to other indications. Soliton is still pre-launch, so the company had little to report for its financials in its latest earnings report. Management spent most of … Read more
Stock Market Commentary The stock market continued its streak of trickiness. Buyers and sellers played a fierce bear-bull battle starting with one of the biggest fake-out one-day rallies since last September 2nd’s near parabolic run-up. Fresh money flowed into funds to start the month of March to for gains of 2.4% on the S&P 500 … Read more
Stock Market Commentary The week ended with a split personality. While the S&P 500 meandered and the NASDAQ flattened, small caps rebounded convincingly. Financials also forged ahead. As a result, the recent end to overbought conditions may only signal (mild) bearish conditions for a portion of the stock market. The Stock Market Indices The S&P … Read more
